Sapan Ghai, CCO at Sovereign Metals, discusses their superior graphite test results. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,792.50
Bid: 1,792.50
Ask: 1,793.00
Change: 12.00 (0.67%)
Spread: 0.50 (0.028%)
Open: 1,784.00
High: 1,794.00
Low: 1,780.00
Prev. Close: 1,780.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Upbeat corporate guidances lift European shares, Nvidia forecast boosts chip stocks

Thu, 23rd Feb 2023 17:22

UK healthcare giants fall on ex-dividend trades

*

WPP leads gains among media stocks

*

AXA rises on guidance hike, surprise share buy-back

*

Rolls-Royce jumps on upbeat profit outlook for 2023

*

Euro zone inflation marginally higher in Jan; core also lifted

*

STOXX 600 up 0.1%

Feb 23 (Reuters) - European shares inched higher on Thursday, after two straight sessions of declines, supported by financial stocks and upbeat guidance by regional companies, while U.S. semiconductor designer Nvidia's positive sales forecast sparked a rally in chip stocks.

The pan-European STOXX 600 index rose 0.1%.

AXA

rose 3.2% after the French insurer raised its 2023 guidance and announced a share buy-back programme, while posting lower-than-expected full-year earnings.

Banks gained 0.9%, while insurers added 0.3%.

Also aiding sentiment, data earlier in the day showed that euro zone inflation was only a

touch higher

than earlier estimated in January, confirming that price growth is now well past its peak.

The rate-sensitive technology sector rose 0.4%, supported by a jump in semiconductor stocks.

Chipmakers ASM International, BE Semiconductor and Aixtron gained between 0.4% and 1.2%.

U.S. peer Nvidia Corp forecast first-quarter revenue above Wall Street estimates on Wednesday, noting a strong boost from the use of its chips in artificial intelligence (AI) services such as chatbots.

The shorter-term demand for chips will get a boost to fuel "an AI gold rush, if you think such a phenomenon will actually materialize," said Greg Bassuk, chief executive at AXS Investments.

However, the worries of central banks raising interest rates for longer still lingered.

The minutes from the U.S. Federal Reserve's last policy meeting released on Wednesday showed nearly all policymakers rallied behind a decision to further slow the pace of interest rate hikes, noting inflation would determine how much further rates needed to rise.

"The starkest takeaway was, arguably, that some policymakers could have gotten behind another 50 basis point increase and all backed further tightening ahead," said Craig Erlam, senior market analyst at OANDA.

Recent data showed French and German economic activity moved into growth territory, while a rebound in U.S. business activity also backed views that interest rates in both economies will remain higher for longer.

Still, the STOXX 600 has risen nearly 9% so far this year, more than double the S&P 500 index's 3.9% rise.

Europe has benefited from better weather, hopes that the economy will narrowly avoid a recession and a boost from China's reopening.

Engineering firm Rolls-Royce surged 23.7%, to the top of the STOXX 600, after the company's CEO forecast more profit growth in 2023 after last year's profit beat expectations.

Auto stocks rose 1.0%, with carmaker Stellantis up 3.6%.

Media stocks were up 0.3%, boosted by a 3.4% rise in British ad group WPP after it forecast better-than-expected organic growth of 3% to 5% for the year.

UK banks and healthcare majors fell, weighing on the FTSE 100 index. Barclays, Standard Chartered , AstraZeneca and GSK fell as they traded without an entitlement for dividend payout. (Reporting by Shreyashi Sanyal in Bengaluru; Editing by Subhranshu Sahu, Savio D'Souza and Andrew Heavens)

More News
18 Dec 2023 10:07

GSK's dostarlimab trial in endometrial cancer meets primary endpoint

(Alliance News) - GSK PLC on Monday said a trial of dostarlimab in combination with niraparib for treating endometrial cancer has met its primary endpoint.

Read more
18 Dec 2023 07:55

LONDON BRIEFING: Games Workshop seals Amazon deal for Warhammer 40,000

(Alliance News) - Stocks in London were set to retreat slightly on Monday, in line with equity markets in Asia, at the start of the last week before the Christmas holidays.

Read more
18 Dec 2023 07:18

GSK sees success in Jemperli endometrial cancer trial

(Sharecast News) - GSK released positive headline results from the planned analysis of its trial of Jemperli in endometrial cancer on Monday.

Read more
17 Dec 2023 15:16

PRESS: GSK looks for deals in China as rebuilds relationship

(Alliance News) - The Financial Times on Sunday reported that GSK PLC is looking for some new deals in China.

Read more
15 Dec 2023 17:08

European shares end fifth week higher on rate-cut optimism

Barclays sees first ECB rate cut in April

*

Read more
15 Dec 2023 16:51

LONDON MARKET CLOSE: FTSE 100 underperforms as post-Fed rally cools

(Alliance News) - London's FTSE 100 ended lower on Friday, with profit-taking and some hawkish words from a US policymaker keeping equities in check at the end of a largely positive week for stocks.

Read more
15 Dec 2023 16:29

PRESS: GSK, Astra and AbbVie in US scrutiny over patents - Bloomberg

(Alliance News) - A US senator has accused AstraZeneca PLC, GSK PLC, AbbVie Inc and other drugmakers of "abusing" the patent system to send prices higher, Bloomberg reported on Thursday.

Read more
12 Dec 2023 10:08

AstraZeneca buys respiratory vaccine developer Icosavax in $1.1 bln deal

Dec 12 (Reuters) - AstraZeneca said on Tuesday it had agreed to buy respiratory syncytial virus (RSV) vaccine developer Icosavax in a deal valued at up to $1.1 billion.

Read more
12 Dec 2023 08:22

TOP NEWS: Japan accepts GSK's filing for respiratory disease vaccine

(Alliance News) - GSK PLC on Tuesday said Japan's Ministry of Health, Labour & Welfare has accepted its regulatory application for the extension of its respiratory syncytial virus vaccine, Arexvy, for adults aged 50-59.

Read more
12 Dec 2023 07:39

LONDON BRIEFING: UK unemployment unchanged at 4.2%; eyes on US CPI

(Alliance News) - Stocks in London are called to open higher, as investors digest the latest UK unemployment data, before turning their heads to US inflation.

Read more
12 Dec 2023 07:24

GSK seeks to extend RSV vaccine approval in Japan

(Sharecast News) - GSK announced on Tuesday that Japan's Ministry of Health, Labour and Welfare (MHLW) has accepted its regulatory application for the extension of the indication of its RSV vaccine to include adults aged 50- to 59 at an increased risk of contracting the disease.

Read more
11 Dec 2023 08:28

GSK drug gets EU marketing backing for form of endometrial cancer

(Alliance News) - GSK PLC on Monday said it won EU backing for its Jemperli drug in tandem with chemotherapy to treat a form of endometrial cancer.

Read more
11 Dec 2023 07:41

LONDON BRIEFING: GSK drug gets EU endorsement; Begbies backs outlook

(Alliance News) - London's FTSE 100 is called to open a touch lower on Monday, kicking off the week with some slight trepidation after Friday's hotter-than-expected US jobs report which offered the dollar some respite.

Read more
11 Dec 2023 07:23

GSK endometrial cancer treatment gets Europe authorisation

(Sharecast News) - GSK announced on Monday that the European Commission has granted marketing authorisation for 'Jemperli', or dostarlimab, in combination with chemotherapy for certain endometrial cancers.

Read more
7 Dec 2023 12:54

THG backer Kelso pushes for demerger to trim "inherent" valuation gap

(Alliance News) - THG PLC investor Kelso Group Holdings PLC on Thursday reiterated its call for a demerger, which the shareholder believes will help close the "disparity" between the e-commerce firm's share price and its true value.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.